Effect of grape and other berries on cardiovascular health

Journal of the Science of Food and Agriculture

Volumn 95, Issue 8, 2015, Pages 1584-1597

  Wightman, Jolynne D ^a   Heuberger, Roschelle A ^b  

^a Welch Foods Inc   (United States)

^b CENTRAL MICHIGAN UNIVERSITY   (United States)

Author keywords

Berry; Cardiovascular health; Endothelial function; Flavonoids; Grape; LDL oxidation

Indexed keywords

VITACEAE;

CARDIOTONIC AGENT; FLAVONOID; LIPID; LOW DENSITY LIPOPROTEIN;

BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; FRUIT; HEALTH PROMOTION; HUMAN; HYPERTENSION; INFLAMMATION; MEDLINE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYTOTHERAPY; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; VITIS;

CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FLAVONOIDS; FRUIT; HEALTH PROMOTION; HUMANS; HYPERTENSION; INFLAMMATION; LIPIDS; LIPOPROTEINS, LDL; MEDLINE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHYTOTHERAPY; PLATELET ACTIVATION; VITIS;

EID: 84928567650     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.6890     Document Type: Review

References (114)

1. World Health Organization, Global Status Report on Noncommunicable Diseases 2010. WHO Press, Geneva (2011).
2. World Health Organization, Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. WHO Press, Geneva (2009).
3. Eckel RH, Jakicic JM, Ard JD, Hubbard VS, de Jesus JM, Lee I-M, et al., 2013 AHA/ACC Guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:S76-S99 (2014).
4. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al., 2013 AHA/ACC/TOS Guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 129:S102-S138 (2014).
5. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al., European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis 194:1-45 (2007).
6. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, et al., Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114:82-96 (2006).
7. Micha R, Kalantarian S, Wirojratana P, Byers T, Danaei G, Elmadfa I, et al., Estimating the global and regional burden of suboptimal nutrition on chronic disease: methods and inputs to the analysis. Eur J Clin Nutr 66:119-129 (2012).
8. Scalbert A, Manach C, Morand C, Rémésy C and Jiménez L, Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287-306 (2005).
9. Manach C, Williamson G, Morand C, Scalbert A and Remesy C, Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S-242S (2005).
10. Williamson G and Manach C, Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81:243S-255S (2005).
11. US Department of Agriculture - Agricultural Research Service, USDA Database for the Flavonoid Content of Selected Foods Release 3.1 [Online]. Available: http://ars.usda.gov/SP2UserFiles/Place/12354500/Data/Flav/Flav3-1.pdf [5 January 2014].
12. Blumberg JB, Camesano TA, Cassidy A, Kris-Etherton P, Howell A, Manach C, et al., Cranberries and their bioactive constituents in human health. Adv Nutr 4:618-632 (2013).
13. Stalmach A, Edwards CA, Wightman JD and Crozier A, Identification of (poly)phenolic compounds in Concord grape juice and their metabolites in human plasma and urine after juice consumption. J Agric Food Chem 59:9512-9522 (2011).
14. Xu Y, Simon JE, Welch C, Wightman JD, Ferruzzi MG, Ho L, et al., Survey of polyphenol constituents in grapes and grape-derived products. J Agric Food Chem 59:10586-10593 (2011).
15. Del Rio D, Borges G and Crozier A, Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 104(Suppl. 3):S67-S90 (2010).
16. Borges G, Degeneve A, Mullen W and Crozier A, Identification of flavonoid and phenolic antioxidants in black currants, blueberries, raspberries, red currants, and cranberries. J Agric Food Chem 58:3901-3909 (2010).
17. Wu X, Gu L, Prior RL and McKay S, Characterization of anthocyanins and proanthocyanidins in some cultivars of Ribes, Aronia, and Sambucus and their antioxidant capacity. J Agric Food Chem 52:7846-7856 (2004).
18. Manach C, Scalbert A, Morand C, Remesy C and Jimenez L, Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727-747 (2004).
19. Tresserra-Rimbau A, Rimm EB, Medina-Remón A, Martínez-González MA, de la Torre R, Corella D, et al., Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. Nutr Metabol Cardiovasc Dis 24:639-647 (2014).
20. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R and Dwyer JT, Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 95:454-464 (2012).
21. González S, Cuervo A and Lasheras C, Polyphenol intake in elderly people is associated with lipid oxidative damage. J Am Coll Nutr 32:384-390 (2013).
22. Hollman PCH, Geelen A and Kromhout D, Dietary flavonol intake may lower stroke risk in men and women. J Nutr 140:600-604 (2010).
23. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, et al., Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 85:895-909 (2007).
24. Jennings A, Welch AA, Fairweather-Tait SJ, Kay C, Minihane A-M, Chowienczyk P, et al., Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr 96:781-788 (2012).
25. Cassidy A, Mukamal KJ, Liu L, Franz M, Eliassen AH and Rimm EB, High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 127:188-196 (2013).
26. Jennings A, Welch AA, Spector T, Macgregor A and Cassidy A, Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women. J Nutr 144:202-208 (2014).
27. Landberg R, Sun Q, Rimm EB, Cassidy A, Scalbert A, Mantzoros CS, et al., Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women. J Nutr 141:618-625 (2011).
28. Watkins TR and Bierenbaum ML, Grape juice attenuates cardiovascular risk factors in the hyperlipemic subject. Pharmaceut Biol 36:75-80 (1998).
29. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP and Goldberg DM, Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 246:163-182 (1996).
30. Keevil JG, Osman H, Maalej N and Folts JD, Grape juice inhibits human ex vivo platelet aggregation while orange and grapefruit juices do not. J Am Coll Cardiol 31:172 (1998).
31. Freedman JE, Parker 3rd C, Li L, Perlman JA, Frei B, Ivanov V, et al., Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103:2792-2798 (2001).
32. Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, et al., Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr 87:323-331 (2008).
33. Ellis CL, Edirisinghe I, Kappagoda T and Burton-Freeman B, Attenuation of meal-induced inflammatory and thrombotic responses in overweight men and women after 6-week daily strawberry (Fragaria) intake. A randomized placebo-controlled trial. J Atheroscler Thromb 18:318-327 (2011).
34. Prospective Studies Collaboration, Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55000 vascular deaths. Lancet 370:1829-1839 (2007).
35. Delles C, Dymott JA, Neisius U, Rocchiccioli JP, Bryce GJ, Moreno MU, et al., Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: an observational study in patients from 2003 and 2007. Atherosclerosis 211:271-277 (2010).
36. Brown BG, Stukovsky KH and Zhao XQ, Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials. Curr Opin Lipidol 17:631-636 (2006).
37. Wilson PW, Anderson KM and Castelli WP, Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study. Am J Med 90:11-16 (1991).
38. Austin MA, Hokanson JE and Edwards KL, Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81:7B-12B (1998).
39. NACB LMPG Committee Members, Myers GL, Christenson RHM, Cushman M, Ballantyne CM, Cooper GR, et al., National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem 55:378-384 (2009).
40. Zern TL, Wood RJ, Greene C, West KL, Liu Y, Aggarwal D, et al., Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 135:1911-1917 (2005).
41. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE and Stroehla BC, Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155:487-495 (2002).
42. Shachter NS, Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol 12:297-304 (2001).
43. Castilla P, Echarri R, Davalos A, Cerrato F, Ortega H, Teruel JL, et al., Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 84:252-262 (2006).
44. Castilla P, Davalos A, Teruel JL, Cerrato F, Fernandez-Lucas M, Merino JL, et al., Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients. Am J Clin Nutr 87:1053-1061 (2008).
45. Khadem-Ansari MH, Rasmi Y and Ramezani F, Effects of red grape juice consumption on high density lipoprotein-cholesterol, apolipoprotein AI, apolipoprotein B and homocysteine in healthy human volunteers. Open Biochem J 4:96-99 (2010).
46. Albers AR, Varghese S, Vitseva O, Vita JA and Freedman JE, The antiinflammatory effects of purple grape juice consumption in subjects with stable coronary artery disease. Arterioscler Thromb Vasc Biol 24:e179-e180 (2004).
47. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S and Folts JD, Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100:1050-1055 (1999).
48. O'Byrne DJ, Devaraj S, Grundy SM and Jialal I, Comparison of the antioxidant effects of Concord grape juice flavonoids and α-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr 76:1367-1374 (2002).
49. Evans M, Wilson D and Guthrie N, A randomized, double-blind, placebo-controlled, pilot study to evaluate the effect of whole grape extract on antioxidant status and lipid profile. J Funct Foods 7:680-691 (2014).
50. Razavi SM, Gholamin S, Eskandari A, Mohsenian N, Ghorbanihaghjo A, Delazar A, et al., Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia. J Med Food 16:255-258 (2013).
51. Vinson JA, Proch J and Bose P, MegaNatural® Gold Grapeseed Extract: in vitro antioxidant and in vivo human supplementation studies. J Med Food 4:17-26 (2001).
52. Chou EJ, Keevil JG, Aeschlimann S, Wiebe DA, Folts JD and Stein JH, Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. Am J Cardiol 88:553-555 (2001).
53. Vigna GB, Costantini F, Aldini G, Carini M, Catapano A, Schena F, et al., Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers. Metabolism 52:1250-1257 (2003).
54. Clifton PM, Effect of grape seed extract and quercetin on cardiovascular and endothelial parameters in high-risk subjects. J Biomed Biotechnol 5:272-278 (2004).
55. Coimbra SR, Lage SH, Brandizzi L, Yoshida V and da Luz PL, The action of red wine and purple grape juice on vascular reactivity is independent of plasma lipids in hypercholesterolemic patients. Braz J Med Biol Res 38:1339-1347 (2005).
56. Sano A, Uchida R, Saito M, Shioya N, Komori Y, Tho Y, et al., Beneficial effects of grape seed extract on malondialdehyde-modified LDL. J Nutr Sci Vitaminol 53:174-182 (2007).
57. Sivaprakasapillai B, Edirisinghe I, Randolph J, Steinberg F and Kappagoda T, Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism 58:1743-1746 (2009).
58. Kar P, Laight D, Rooprai HK, Shaw KM and Cummings M, Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabet Med 26:526-531 (2009).
59. Chaves AA, Joshi MS, Coyle CM, Brady JE, Dech SJ, Schanbacher BL, et al., Vasoprotective endothelial effects of a standardized grape product in humans. Vasc Pharmacol 50:20-26 (2009).
60. Park YK, Lee SH, Park E, Kim J-S and Kang M-H, Changes in antioxidant status, blood pressure, and lymphocyte DNA damage from grape juice supplementation. Ann NY Acad Sci 1171:385-390 (2009).
61. van Mierlo LAJ, Zock PL, van der Knaap HCM and Draijer R, Grape polyphenols do not affect vascular function in healthy men. J Nutr 140:1769-1773 (2010).
62. Mellen PB, Daniel KR, Brosnihan KB, Hansen KJ and Herrington DM, Effect of Muscadine grape seed supplementation on vascular function in subjects with or at risk for cardiovascular disease: a randomized crossover trial. J Am Coll Nutr 29:469-475 (2010).
63. Dohadwala MM, Hamburg NM, Holbrook M, Kim BH, Duess M-A, Levit A, et al., Effect of grape juice on ambulatory blood pressure in pre-hypertension and Stage 1 hypertension. Am J Clin Nutr 92:1052-1059 (2010).
64. Kelishadi R, Gidding SS, Hashemi M, Hashemipour M, Zakerameli A and Poursafa P, Acute and long term effects of grape and pomegranate juice consumption on endothelial dysfunction in pediatric metabolic syndrome. J Res Med Sci 16:245-253 (2011).
65. Tomé-Carneiro J, Gonzálvez M, Larrosa M, García-Almagro FJ, Avilés-Plaza F, Parra S, et al., Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial. Mol Nutr Food Res 56:810-821 (2012).
66. Barona J, Aristizabal JC, Blesso CN, Volek JS and Fernandez ML, Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J Nutr 142:1626-1632 (2012).
67. Siasos G, Tousoulis D, Kokkou E, Oikonomou E, Kollia ME, Verveniotis A, et al., Favorable effects of Concord grape juice on endothelial function and arterial stiffness in healthy smokers. Am J Hypertens 27:38-45 (2014).
68. Karlsen A, Paur I, Bohn SK, Sakhi AK, Borge GI, Serafini M, et al., Bilberry juice modulates plasma concentration of NF-κB related inflammatory markers in subjects at increased risk of CVD. Eur J Nutr 49:345-355 (2010).
69. Basu A, Du M, Leyva MJ, Sanchez K, Betts NM, Wu M, et al., Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr 140:1582-1587 (2010).
70. Nyberg S, Gerring E, Gjellan S, Vergara M, Lindström T and Nystrom FH, Effects of exercise with or without blueberries in the diet on cardio-metabolic risk factors: an exploratory pilot study in healthy subjects. Ups J Med Sci 118:247-255 (2013).
71. Riso P, Klimis-Zacas D, Del Bo C, Martini D, Campolo J, Vendrame S, et al., Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors. Eur J Nutr 52:949-961 (2013).
72. Lee IT, Chan YC, Lin CW, Lee WJ and Sheu WHH, Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes. Diabet Med 25:1473-1477 (2008).
73. Shidfar F, Heydari I, Hajimiresmaiel SJ, Hosseini S, Shidfar S and Amiri F, The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients. J Res Med Sci 17:355-360 (2012).
74. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B and Couillard C, Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. Br J Nutr 96:357-364 (2006).
75. Ruel G, Pomerleau S, Couture P, Lamarche B and Couillard C, Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism 54:856-861 (2005).
76. Basu A, Betts NM, Ortiz J, Simmons B, Wu M and Lyons TJ, Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutr Res 31:190-196 (2011).
77. Flammer AJ, Martin EA, Gössl M, Widmer RJ, Lennon RJ, Sexton JA, et al., Polyphenol-rich cranberry juice has a neutral effect on endothelial function but decreases the fraction of osteocalcin-expressing endothelial progenitor cells. Eur J Nutr 52:289-296 (2013).
78. Basu A, Wilkinson M, Penugonda K, Simmons B, Betts NM and Lyons TJ, Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome: baseline and post intervention effects. Nutr J 8:43 (2009).
79. Basu A, Fu DX, Wilkinson M, Simmons B, Wu M, Betts NM, et al., Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome. Nutr Res 30:462-469 (2010).
80. Burton-Freeman B, Linares A, Hyson D and Kappagoda T, Strawberry modulates LDL oxidation and postprandial lipemia in response to high-fat meal in overweight hyperlipidemic men and women. J Am Coll Nutr 29:46-54 (2010).
81. Jenkins DJA, Nguyen TH, Kendall CWC, Faulkner DA, Bashyam B, Kim IJ, et al., The effect of strawberries in a cholesterol-lowering dietary portfolio. Metabolism 57:1636-1644 (2008).
82. Diaz MN, Frei B, Vita JA and Keaney Jr JF, Antioxidants and atherosclerotic heart disease. New Engl J Med 337:408-416 (1997).
83. Miyagi Y, Miwa K and Inoue H, Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol 80:1627-1631 (1997).
84. Ward NC, Hodgson JM, Croft KD, Burke V, Beilin LJ and Puddey IB, The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 23:427-434 (2005).
85. McAnulty SR, McAnulty LS, Morrow JD, Khardouni D, Shooter L, Monk J, et al., Effect of daily fruit ingestion on angiotensin converting enzyme activity, blood pressure, and oxidative stress in chronic smokers. Free Radic Res 39:1241-1248 (2005).
86. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B and Couillard C, Low-calorie cranberry juice supplementation reduces plasma oxidized LDL and cell adhesion molecule concentrations in men. Br J Nutr 99:352-359 (2008).
87. Ruel G, Lapointe A, Pomerleau S, Couture P, Lemieux S, Lamarche B, et al., Evidence that cranberry juice may improve augmentation index in overweight men. Nutr Res 33:41-49 (2013).
88. Hiki M, Shimada K, Ohmura H, Kiyanagi T, Kume A, Sumiyoshi K, et al., Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease. J Cardiol 53:108-116 (2009).
89. Cathcart MK, Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 24:23-28 (2004).
90. Ridker PM, Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363-369 (2003).
91. Legein B, Temmerman L, Biessen EA and Lutgens E, Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci 70:3847-3869 (2013).
92. Valen G, Yan Z and Hansson GK, Nuclear factor κ-B and the heart. J Am Coll Cardiol 38:307-314 (2001).
93. Barona J, Blesso CN, Andersen CJ, Park Y, Lee J and Fernandez ML, Grape consumption increases anti-inflammatory markers and upregulates peripheral nitric oxide synthase in the absence of dyslipidemias in men with metabolic syndrome. Nutrients 4:1945-1957 (2012).
94. Ansar W and Ghosh S, C-reactive protein and the biology of disease. Immunol Res 56:131-142 (2013).
95. Dohadwala MM, Holbrook M, Hamburg NM, Shenouda SM, Chung WB, Titas M, et al., Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am J Clin Nutr 93:934-940 (2011).
96. Widlansky ME, Gokce N, Keaney JJF and Vita JA, The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42:1149-1160 (2003).
97. Korkmaz H and Onalan O, Evaluation of endothelial dysfunction: flow-mediated dilation. Endothelium 15:157-163 (2008).
98. Hamburg NM and Benjamin EJ, Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med 19:6-11 (2009).
99. Lind L, Relationships between three different tests to evaluate endothelium-dependent vasodilation and cardiovascular risk in a middle-aged sample. J Hypertens 31:1570-1574 (2013).
100. Lekakis J, Rallidis LS, Andreadou I, Vamvakou G, Kazantzoglou G, Magiatis P, et al., Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 12:596-600 (2005).
101. Hashimoto M, Kim S, Eto M, Iijima K, Ako J, Yoshizumi M, et al., Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am J Cardiol 88:1457-1460 (2001).
102. Papamichael C, Karatzis E, Karatzi K, Aznaouridis K, Papaioannou T, Protogerou A, et al., Red wine's antioxidants counteract acute endothelial dysfunction caused by cigarette smoking in healthy nonsmokers. Am Heart J 147:E5 (2004).
103. Hampton SM, Isherwood C, Kirkpatrick VJE, Lynne-Smith AC and Griffin BA, The influence of alcohol consumed with a meal on endothelial function in healthy individuals. J Hum Nutr Diet 23:120-125 (2010).
104. Del Bo C, Riso P, Campolo J, Møller P, Loft S, Klimis-Zacas D, et al., A single portion of blueberry (Vaccinium corymbosum L) improves protection against DNA damage but not vascular function in healthy male volunteers. Nutr Res 33:220-227 (2013).
105. Laurent S, Briet M and Boutouyrie P, Arterial stiffness as surrogate end point: needed clinical trials. Hypertension 60:518-522 (2012).
106. Gossl M, Modder UI, Gulati R, Rihal CS, Prasad A, Loeffler D, et al., Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur Heart J 31:2909-2914 (2010).
107. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al., Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206-1252 (2003).
108. Wengreen H, Munger RG, Cutler A, Quach A, Bowles A, Corcoran C, et al., Prospective study of Dietary Approaches to Stop Hypertension- and Mediterranean-style dietary patterns and age-related cognitive change: the Cache County Study on Memory, Health and Aging. Am J Clin Nutr 98:1263-1271 (2013).
109. Prospective Studies Collaboration, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903-1913 (2002).
110. Park YK, Kim J-S and Kang M-H, Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. Biofactors 22:145-147 (2004).
111. Ras RT, Zock PL, Zebregs YE, Johnston NR, Webb DJ and Draijer R, Effect of polyphenol-rich grape seed extract on ambulatory blood pressure in subjects with pre- and stage I hypertension. Br J Nutr 110:2234-2241 (2013).
112. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L and Bursztyn M, Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension 49:1235-1241 (2007).
113. Sayk F, Becker C, Teckentrup C, Fehm H-L, Struck J, Wellhoener JP, et al., To dip or not to dip: on the physiology of blood pressure decrease during nocturnal sleep in healthy humans. Hypertension 49:1070-1076 (2007).
114. Feringa HH, Laskey DA, Dickson JE and Coleman CI, The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc 111:1173-1181 (2011).